Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
https://www.timeshighereducation.com/unijobs/listing/399157/research-fellow-pri… Requirements Additional Information Work Location(s) Number of offers available1Company/InstituteUNIVERSITY
-
. Where to apply Website https://www.timeshighereducation.com/unijobs/listing/399158/lecturer-in-predict… Requirements Additional Information Work Location(s) Number of offers available1Company
-
until 16/05/2026. Informal inquiries should be directed to Dr Matthew Blunt (m.d.blunt@soton.ac.uk ). Where to apply Website https://www.timeshighereducation.com/unijobs/listing/398103/research-technician
-
, and be expected to develop a programme of research with support from clinical and laboratory-based colleagues. They will contribute to academic leadership within the Faculty and Trust and enhance
-
) Interviews will take place via Teams. The position is tenable from 1st of November 2025. Where to apply Website https://www.timeshighereducation.com/unijobs/listing/397573/research-fellow-sch… Requirements
-
the development of new anchoring technologies for floating offshore wind turbines. Your role will focus primarily on the development of simplified computational models, and you will contribute
-
and size-exclusion chromatography. Prepare samples for glycan and glycoprotein analysis, including LC-MS workflows. Glycomics & Structural Biology Support Assist in developing high-throughput glycomics
-
The Senior Research Fellow will lead the development of structural and computational approaches to engineer antibody-modifying and antibody-degrading enzymes for applications in biology and
-
immunogens, the postholder will develop and apply advanced glycomics and glycoproteomics methodologies to generate high-quality datasets that inform next-generation vaccine design. They will provide
-
The Glycoprotein Therapeutics Laboratory, led by Professor Max Crispin, focuses on developing antiviral vaccines and antibody-based therapies against cancer. A key area of interest is HIV vaccine